Follow the DSM-Firmenich AG stock price and the full insider trade history of the company, a listed issuer based in Switzerland. Shares are listed on the CH market, under the supervision of SIX SER. Market capitalisation: €27.2bn. The latest transaction was reported on 29 June 2026 (Sale). Every trade is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€2m
2 ops.
Sell Volume
28Σ signal
Buys n/a€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,193 of 29,063 companies
44.2
score / 100
Value
48
Quality
40
FCF yld2.4%
Earn yld-4.1%
EV/EBITDA8.4x
ROE1.9%
Gross mgn39%
Net mgn-12%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 June 2026
Declarations2 total
●
Anonymous (an executive member of the board of directors / member of senior management)
an executive member of the board of directors / member of senior management·Executives·(filed)
14,093 shares@ CHF 73.76430.0056% mcap100.0% of flowISINISIN CH1216478797SIX:T1Q6T00087
2 of 2 declarations
About DSM-Firmenich AG
DSM-Firmenich AG is a company specializing in life sciences and consumer ingredients, resulting from the merger of DSM and Firmenich. It primarily operates on the Swiss stock market.